Caitong International Asset Management Co., LTD Edgewise Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 3,194 shares of EWTX stock, worth $41,905. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,194
Previous 2,053
55.58%
Holding current value
$41,905
Previous $54.8 Million
28.19%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$197 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$117 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$85.9 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$80.8 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$78.9 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $829M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...